Status | Study |
Active, not recruiting |
Study Name: Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection Condition: HCV Coinfection HIV Infection Date: 2013-07-12 Interventions: Drug: Raltegravir Patients on |
Completed |
Study Name: Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB Condition: HIV/TB Co-infection Date: 2013-03-01 Interventions: Drug: Nevirapine The regimen c |
Completed |
Study Name: Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection Condition: Hiv Date: 2012-12-14 Interventions: Drug: Regimen:TDF+3TC+EFV TDF+3TC+EFV for HIV/HBV co-infection |
Completed |
Study Name: Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders Condition: HCV-HIV Co-Infection Date: 2012-10-22 Interventions: Drug: Asunaprevir, Daclatasvir, Ribavirin and Peginterferon alfa-2a |
Completed |
Study Name: Co-infections in Children Hospitalised for Bronchiolitis Condition: Bronchiolitis Date: 2012-10-08 Interventions: Other: cohort isolation all patients hospitalised for bronchiolitis are nursed in one room together, sep |
Completed |
Study Name: Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection Condition: HCV Coinfection HIV Infection Date: 2012-02-05 Interventions: Drug: Nitazoxanide Nitazoxanide 500 mg bid po for 4 weeks, followed by nitazoxanide 500 mg bid plus pegy |
Completed |
Study Name: Prevalence of Occult HBV Infection Among Anti-HBc Alone Group in Northern Taiwan Condition: HBV Coinfection Date: 2011-07-04 |
Completed |
Study Name: Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin Condition: HCV Coinfection HIV-1 Infection Date: 2011-03-25 Interventions: Drug: Boceprevir, Peg-interferon alfa 2b and Ribavirin |
Completed |
Study Name: A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B Condition: HIV Coinfection Date: 2011-03-22 Interventions: Drug: Maraviroc 150mg, 300mg o |
Completed |
Study Name: Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection Condition: HIV Infections Liver Toxicity Hepatitis Date: 2011-01-06 |